Literature DB >> 21331698

Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis.

Joo Youn Oh, Mee Kum Kim, Won Ryang Wee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21331698     DOI： 10.1007/s10384-010-0889-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN： 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  5 in total

1.  Infliximab therapy for refractory uveitis: 2-year results of a prospective trial.

Authors:  Eric B Suhler; Justine R Smith; Tracy R Giles; Andreas K Lauer; Michael S Wertheim; Daryl E Kurz; Paul A Kurz; Lyndell Lim; Friederike Mackensen; Terri D Pickard; James T Rosenbaum
Journal:  Arch Ophthalmol       Date:  2009-06

2.  Eye loss by exogenous endophthalmitis following anti-tumor necrosis factor therapy: a report of 3 cases.

Authors:  Benoit Le Goff; Bertrand Vabres; Isabelle Cochereau; Beatrice Bouvard; Cedric Lamirel; Yves Maugars; Jean-Marie Berthelot
Journal:  J Rheumatol       Date:  2009-01       Impact factor: 4.666

3.  Therapy of progressive rheumatoid arthritis-associated corneal ulceration with infliximab.

Authors:  Justus W Thomas; Stephen C Pflugfelder
Journal:  Cornea       Date:  2005-08       Impact factor: 2.651

4.  Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis.

Authors:  G Simonini; M E Zannin; R Caputo; F Falcini; M de Martino; F Zulian; R Cimaz
Journal:  Rheumatology (Oxford)       Date:  2008-08-01       Impact factor: 7.580

5.  Retrospective analysis of children with uveitis treated with infliximab.

Authors:  Ilknur Tugal-Tutkun; Ozen Ayranci; Ozgür Kasapcopur; Nur Kir
Journal:  J AAPOS       Date:  2008-10-19       Impact factor: 1.220
  5 in total
  8 in total

Review 1.  Biologic therapy for refractory scleritis: a new treatment perspective.

Authors:  Tania Sales de Alencar de Fidelix; Luis Antonio Vieira; Denise de Freitas; Virginia Fernandes Moça Trevisani
Journal:  Int Ophthalmol       Date:  2015-08-29       Impact factor: 2.031

Review 2.  Peripheral Ulcerative Keratitis: A Review.

Authors:  Kiana Hassanpour; Reem H ElSheikh; Amir Arabi; Charles R Frank; Abdelrahman M Elhusseiny; Taher K Eleiwa; Shiva Arami; Ali R Djalilian; Ahmad Kheirkhah
Journal:  J Ophthalmic Vis Res       Date:  2022-04-29

Review 3.  Management of inflammatory corneal melt leading to central perforation in children: a retrospective study and review of literature.

Authors:  A Medsinge; E Gajdosova; W Moore; K K Nischal
Journal:  Eye (Lond)       Date:  2016-01-29       Impact factor: 3.775

4.  Update on peripheral ulcerative keratitis.

Authors:  Ayse Yagci
Journal:  Clin Ophthalmol       Date:  2012-05-14

Review 5.  Infliximab for peripheral ulcerative keratitis treatment.

Authors:  Valentín Huerva; Francisco J Ascaso; Andrzej Grzybowski
Journal:  Medicine (Baltimore)       Date:  2014-11       Impact factor: 1.889

6.  Partial and Total Descemet's Detachments in a Patient with Severe Terrien's Marginal Degeneration and Juvenile Idiopathic Arthritis.

Authors:  Amir Hossein Vejdani; Hamid Khakshoor; Michael V McCaughey; Majid Moshirfar
Journal:  Case Rep Ophthalmol Med       Date:  2014-07-20

7.  Health system wide "big data" analysis of rheumatologic conditions and scleritis.

Authors:  Meghan K Berkenstock; Andrew R Carey
Journal:  BMC Ophthalmol       Date:  2021-01-06       Impact factor: 2.209

Review 8.  Biologic Therapies and Small Molecules for the Management of Non-Infectious Scleritis: A Narrative Review.

Authors:  Jurgen Sota; Matteo-Maria Girolamo; Bruno Frediani; Gian Marco Tosi; Luca Cantarini; Claudia Fabiani
Journal:  Ophthalmol Ther       Date:  2021-09-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.